UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Overview of the IL‐1 family in innate inflammation and acquired immunity

Immunological reviews, 2018-01, Vol.281 (1), p.8-27

Dinarello, Charles A.

2018

Volltextzugriff (PDF)

Historical insights into cytokines

European journal of immunology, 2007-11, Vol.37 (S1), p.34-45

Dinarello, Charles A

2007

Volltextzugriff (PDF)

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

Circulation research, 2020-04, Vol.126 (9), p.1260-1280

2020

Volltextzugriff (PDF)

Anakinra Therapy for Non-cancer Inflammatory Diseases

Frontiers in pharmacology, 2018-11, Vol.9, p.1157-1157

2018

Volltextzugriff (PDF)

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis

International journal of molecular sciences, 2019-07, Vol.20 (13), p.3318

2019

Volltextzugriff (PDF)

Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19

Proceedings of the National Academy of Sciences - PNAS, 2020-08, Vol.117 (32), p.18951-18953

2020

Volltextzugriff (PDF)

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

Nature reviews. Drug discovery, 2012-08, Vol.11 (8), p.633-652

2012

Volltextzugriff (PDF)

IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance

Cytokine (Philadelphia, Pa.), 2015-10, Vol.75 (2), p.280-290

2015

Volltextzugriff (PDF)

OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis

Frontiers in immunology, 2019-11, Vol.10, p.2578-2578

2019

Volltextzugriff (PDF)

Interleukin-18 and the Pathogenesis of Inflammatory Diseases

Seminars in nephrology, 2007, Vol.27 (1), p.98-114

Dinarello, Charles A

2007

Volltextzugriff (PDF)

Treating Life-Threatening Myocarditis by Blocking Interleukin-1

Critical care medicine, 2016-08, Vol.44 (8), p.e751-e754

2016

Volltextzugriff (PDF)

Toll-like receptors and chronic inflammation in rheumatic diseases: new developments

Nature reviews. Rheumatology, 2016-06, Vol.12 (6), p.344-357

2016

Volltextzugriff (PDF)

Proinflammatory Cytokines

Chest, 2000-08, Vol.118 (2), p.503-508

Dinarello, Charles A.

2000

Volltextzugriff (PDF)

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

Proceedings of the National Academy of Sciences - PNAS, 2012-02, Vol.109 (8), p.3001-3005

2012

Volltextzugriff (PDF)

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Arthritis research & therapy, 2019-02, Vol.21 (1), p.54-54, Article 54

2019

Volltextzugriff (PDF)

Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (6), p.2574-2579

2010

Volltextzugriff (PDF)

IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer’s disease mouse model

eLife, 2022-08, Vol.11

2022

Volltextzugriff (PDF)

Metabolic reprogramming of the inflammatory response in the nervous system: the crossover between inflammation and metabolism

Neural regeneration research, 2024-10, Vol.19 (10), p.2189-2201

2024

Volltextzugriff (PDF)

MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo

Proceedings of the National Academy of Sciences - PNAS, 2016-02, Vol.113 (5), p.1363-1368

2016

Volltextzugriff (PDF)

IL-37: a new anti-inflammatory cytokine of the IL-1 family

European cytokine network, 2011-09, Vol.22 (3), p.127-147

2011

Volltextzugriff (PDF)

Innate immune response of human alveolar macrophages during influenza A infection

PloS one, 2012-03, Vol.7 (3), p.e29879-e29879

2012

Volltextzugriff (PDF)

α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood

Journal of leukocyte biology, 2009-05, Vol.85 (5), p.886-895

2009

Volltextzugriff (PDF)

Interleukin-1 as a mediator of fatigue in disease: a narrative review

Journal of neuroinflammation, 2017-01, Vol.14 (1), p.16-16, Article 16

2017

Volltextzugriff (PDF)

Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease

Proceedings of the National Academy of Sciences - PNAS, 2010-02, Vol.107 (7), p.3030-3033

2010

Volltextzugriff (PDF)

Why not treat human cancer with interleukin-1 blockade?

Cancer and metastasis reviews, 2010-06, Vol.29 (2), p.317-329

Dinarello, Charles A.

2010

Volltextzugriff (PDF)

1 – 25 von 154

Suche als RSS-Feed

Aktive Filter

ThemaMice

ThemaInflammation

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(149)
Mit Volltextzugriff
(133)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(125)
Life Sciences & Biomedicine
(107)
Humans
(98)
Cytokines
(81)
Immunology
(41)
Animals
(35)
Male
(31)
Biological And Medical Sciences
(28)
Cell Biology
(26)
Female
(23)
Interleukin 1
(23)
Biochemistry & Molecular Biology
(22)
Adult
(20)
Middle Aged
(20)
Proteins
(20)
Multidisciplinary Sciences
(19)
Science & Technology - Other Topics
(19)
Biological Sciences
(16)
Gene Expression
(16)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overview of the IL‐1 family in innate inflammation and acquired immunity

Historical insights into cytokines

Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease

Anakinra Therapy for Non-cancer Inflammatory Diseases

The Significance of IL-36 Hyperactivation and IL-36R Targeting in Psoriasis

Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

IL-1 family members in the pathogenesis and treatment of metabolic disease: Focus on adipose tissue inflammation and insulin resistance

OLT1177 (Dapansutrile), a Selective NLRP3 Inflammasome Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis Pathogenesis

Interleukin-18 and the Pathogenesis of Inflammatory Diseases

Treating Life-Threatening Myocarditis by Blocking Interleukin-1

Toll-like receptors and chronic inflammation in rheumatic diseases: new developments

Proinflammatory Cytokines

IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist

Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease

Differential release of chromatin-bound IL-1α discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation

IL-37 expression reduces acute and chronic neuroinflammation and rescues cognitive impairment in an Alzheimer’s disease mouse model

Metabolic reprogramming of the inflammatory response in the nervous system: the crossover between inflammation and metabolism

MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo

IL-37: a new anti-inflammatory cytokine of the IL-1 family

Innate immune response of human alveolar macrophages during influenza A infection

α-1-Antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood

Interleukin-1 as a mediator of fatigue in disease: a narrative review

Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease

Why not treat human cancer with interleukin-1 blockade?

Aktive Filter

Suchergebnisse filtern